CBIZ, Inc. (CBZ)
NYSEIndustrialsSpecialty Business ServicesSnapshot 2026-09-04
$54.85-0.11%
Close 2026-09-04 · 1-day change
NYSEIndustrialsSpecialty Business ServicesSnapshot 2026-09-04
Intact: The reason to own it still holds.
CBIZ guides revenue of $2.8B to $2.9B for 2026, showing stable growth. Free cash flow is expected between $270M and $290M, supporting capital returns. The company has a long-standing share buyback program, enhancing shareholder value. Valuation is cheap with a P/E of 9.84 versus peers at 29.26.
Revenue growth may stall below guidance due to recent quarterly declines. Free cash flow could fall short of targets, limiting buybacks. Management changes and mixed execution raise risks. The sector faces headwinds that could pressure margins and demand.
The market prices CBIZ about 47% below our $69.63 fair value, reflecting modest 5% revenue growth expectations. Our fair value is well above the Street median, indicating upside if guidance is met and execution improves.
Breaks if: free cash flow falls below $270M in FY26
Breaks if: revenue falls below $2.8B in FY26
Breaks if: Buyback program is discontinued or materially reduced
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround story within the industrial sector. The current thesis state indicates a cautious approach, as recent performance has been below industry peers, yet there are signs of potential recovery.
The market currently prices CBZ as cheap compared to its peers, reflecting a negative expectations gap. However, the fragility of its earnings quality suggests that the market is not fully accounting for potential execution risks.
Management is focused on driving revenue growth and maintaining strong cash flow, which has shown some success in the first half of 2026. However, recent financial performance has been mixed, with a notable decline in net income in Q2, indicating potential near-term risks.
The long-term thesis hinges on CBZ's ability to sustain revenue growth and manage its acquisitions effectively. Additionally, the performance of sector bellwethers will be crucial, as their results could influence CBZ's trajectory in the coming months.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats impacting the thesis at this time.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
In the next 1 to 3 years, CBZ's performance will depend on its execution and the broader industrial sector's health. Not investment advice.